Harvest Healthcare Leaders Income ETF

Historical Distributions

2019

Record DateDistributions
2019-10-310.058
2019-09-300.058
2019-08-300.058
2019-07-310.058
2019-06-280.058
2019-05-310.058
2019-04-300.058
2019-03-290.058
2019-02-280.058
2019-01-310.058

2018

Record DateDistributions
2018-12-310.058
2018-11-300.058
2018-10-310.058
2018-09-280.058
2018-08-310.058
2018-07-310.058
2018-06-290.058
2018-05-310.058
2018-04-300.058
2018-03-290.058
2018-02-280.058
2018-01-310.058

2017

Record DateDistributions
2017-12-290.058
2017-11-300.058
2017-10-310.058
2017-09-290.058
2017-08-310.058
2017-07-310.058
2017-06-300.058
2017-05-310.058
2017-04-280.058
2017-03-310.058
2017-02-280.058
2017-01-310.058

2016

Record DateDistributions
2016-12-300.058
2016-11-300.058
2016-10-310.058
2016-09-300.058
2016-08-310.058
2016-07-290.058
2016-06-300.058
2016-05-310.058
2016-04-290.058
2016-03-310.058
2016-02-290.058
2016-01-290.058

2015

Record DateDistributions
2015-12-310.058
2015-11-300.058
2015-10-300.058
2015-09-300.058
2015-08-310.058
2015-07-310.058
2015-06-300.058
2015-05-290.058
2015-04-300.058
2015-03-310.058
2015-02-270.058
2015-01-300.058

October 31, 2019

Security %
AstraZeneca PLC 5.2
Bristol-Myers Squibb Company 5.1
GlaxoSmithKline PLC 5.0
Boston Scientific Corporation 5.0
HCA Healthcare, Inc. 5.0
Anthem, Inc. 5.0
Amgen Inc. 5.0
Eli Lilly and Company 4.9
Pfizer Inc. 4.9
AbbVie Inc. 4.9
Merck & Co., Inc. 4.9
UnitedHealth Group Incorporated 4.9
Gilead Sciences, Inc. 4.9
Medtronic PLC 4.8
Stryker Corporation 4.8
Johnson & Johnson 4.8
Abbott Laboratories 4.8
Regeneron Pharmaceuticals, Inc. 4.8
Sanofi S.A. 4.7
Allergan PLC 4.7
Cash and other assets and liabilities 2.4
Foreign currency forwards 0.7
Market value of equity options (1.2)

  

Date Symbol NAV $ NAV $ Change MKT $ MKT $ Change Distribution Total $

(Since Inception)

2019-11-20HHL7.80-0.027.79-0.023.381
2019-11-20HHL.U7.88-0.027.900.001.924

Fund Quick Facts

October 31, 2019


TSX Code HHL  |  HHL.U
Cusip (HHL) 41755F107
Cusip (HHL.U) 41755F206
Net AUM $379 million
Currency (HHL) Hedged to CAD
Currency (HHL.U) Unhedged
Management Fee 0.85%
Total Holdings 23
Income Distribution Monthly
Recent Distribution $0.0583
Distribution Method Cash or DRIP
Eligible RRSP/RRIF/RESP/TFSA
Risk Rating Medium

Portfolio Analysis*


Average Market Capitalization (CA) $169B
Number of Equity Securities 20
Average Dividend Yield 1.97%
Average P/E 16.9x
5 Year Average Return on Equity 18.92%
Current Yield 9.15%

Investor Documents

Why Invest  Eng | Fr


Products Booklet  Eng | Fr


Quarterly Summary  Eng


Prospectus  Eng | Fr


ETF Facts HHL  Eng | Fr


ETF Facts HHL.U  Eng | Fr


Investor Brochure  Eng

Fund Overview

The Fund invests in an equally-weighted portfolio of equity securities of 20 Healthcare Issuers from the Healthcare Leaders Investable Universe that have a minimum market capitalization of US$5 billion at the time of investment and have options in respect of their Equity Securities listed on a recognized options exchange. The portfolio is rebalanced quarterly back to equal weights.

The Fund’s investment objectives are to provide Unitholders with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of Portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly.

In order to seek to generate additional returns, the Investment Manager will sell call options each month on Equity Securities held in the Portfolio.

The Fund’s distribution target is $0.0583 per Class A Unit per month ($0.70 per annum) or US$0.0583 per Class U Unit per month (US$0.70 per annum).

Investor Suitability
Investors seeking a regular income through investment in the worlds leading healthcare companies.

Investors seeking to hold their investment for medium to long term.
Portfolio Management
Paul MacDonald

Harvest Portfolios Group Inc.

PAUL MACDONALD, CFA
Chief Investment Officer

Portfolio Manager JAMES LEARMONTH, CFA
Senior Portfolio Manager
MIKE DRAGOSITS, CFA
Portfolio Manager

Top Ten Portfolio Holdings


Security %
AstraZeneca PLC 5.2
Bristol-Myers Squibb Company 5.1
GlaxoSmithKline PLC 5.0
Boston Scientific Corporation 5.0
HCA Healthcare, Inc. 5.0
Anthem, Inc. 5.0
Amgen Inc. 5.0
Eli Lilly and Company 4.9
Pfizer Inc. 4.9
AbbVie Inc. 4.9

Cumulative Growth $10,000 Invested

(NAV pricing)


Disclaimer

Harvest Healthcare Leaders Income ETF

The Fund originally commenced operations as a TSX listed closed-end fund on December 18, 2014 and converted into an exchange-traded fund on October 24, 2016.  Commissions, management fees and expenses all may be associated with investing in Harvest Exchange Traded Funds (managed by Harvest Portfolios Group Inc.). Please read the relevant prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. The funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into Class A or Class U units of the Fund. If the Fund earns less than the amounts distributed, the difference is a return of capital. Tax, investment and all other decisions should be made with guidance from a qualified professional.

*Source: Bloomberg.  Average statistics calculated based on portfolio weighted average. Dividend yield based on Bloomberg indicated 12 month yield of portfolios positions and does not represent the distribution yield paid to investors. P/E calculated based on Bloomberg consensus 12 month forward earnings estimates. Return on Equity (ROE) based on 5 year trailing average ROE. The above information is for illustrative purposes only, is estimated and unaudited.